{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:06:56Z","timestamp":1789636016272,"version":"4.0.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.imbio.2026.153232","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:23:57Z","timestamp":1787034237000},"page":"153232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling"],"prefix":"10.1016","volume":"231","author":[{"given":"Zhenfeng","family":"Zong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.rcl.2018.01.011","article-title":"Lung Cancer: Posttreatment Imaging: Radiation Therapy and Imaging Findings","volume":"56","author":"Benveniste","year":"2018","journal-title":"Radiol. Clin. North Am."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41588-023-01592-8","article-title":"The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance","volume":"56","author":"Caswell","year":"2024","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0015","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41467-022-28158-2","article-title":"USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.imbio.2026.153232_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20051151","article-title":"Nanog signaling mediates radioresistance in ALDH-positive breast cancer cells","volume":"20","author":"Dehghan Harati","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cpt.2022.09.001","article-title":"PI3K\/AKT\/mTOR pathway, hypoxia, and glucose metabolism: potential targets to overcome radioresistance in small cell lung cancer","volume":"1","author":"Deng","year":"2023","journal-title":"Cancer Pathog Ther"},{"key":"10.1016\/j.imbio.2026.153232_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216568","article-title":"Blocking MARCO(+) tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway","volume":"582","author":"Ding","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.imbio.2026.153232_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109783","article-title":"MARCO is a potential prognostic and immunotherapy biomarker","volume":"116","author":"Dong","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.imbio.2026.153232_bb0040","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.imbio.2026.153232_bb0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thorsurg.2020.01.002","article-title":"Combining Immunotherapy with Radiation Therapy in Non-Small Cell Lung Cancer","volume":"30","author":"Fitzgerald","year":"2020","journal-title":"Thorac. Surg. Clin."},{"issue":"4","key":"10.1016\/j.imbio.2026.153232_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11864-017-0467-z","article-title":"Optimal Radiation Therapy for Small Cell Lung Cancer","volume":"18","author":"Gensheimer","year":"2017","journal-title":"Curr. Treat. Options Oncol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4049\/jimmunol.2300029","article-title":"Cancer Cells Promote Immune Regulatory Function of Macrophages by Upregulating Scavenger Receptor MARCO Expression","volume":"211","author":"Gu","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2026.153232_bb0060","doi-asserted-by":"crossref","unstructured":"He J, Li M, Bao J, Peng Y, Xue W, Chen J, Zhao J: \u03b2-Elemene promotes ferroptosis and reverses radioresistance in gastric cancer by inhibiting the OTUB1-GPX4 interaction. Front. Pharmacol. 2024, Volume 15\u20132024.","DOI":"10.3389\/fphar.2024.1469180"},{"issue":"000","key":"10.1016\/j.imbio.2026.153232_bb0065","article-title":"Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect","volume":"123","author":"Hu","year":"2024","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.imbio.2026.153232_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20250077","article-title":"Unveiling large multimodal models in pulmonary CT: a comparative assessment of generative AI performance in lung cancer diagnostics","volume":"6","author":"Huang","year":"2025","journal-title":"VIEW"},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0080","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.imbio.2026.153232_bb0085","article-title":"Radioresistance in prostate cancer: focus on the interplay between NF-kappaB and SOD","volume":"10","author":"Kumar","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.imbio.2026.153232_bb0090","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/0008-5472.CAN-20-1885","article-title":"Targeting MARCO and IL37R on immunosuppressive macrophages in lung cancer blocks regulatory T cells and supports cytotoxic lymphocyte function","volume":"81","author":"La Fleur","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0095","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1038\/s41598-022-07653-y","article-title":"Characterization of gamma-H2AX foci formation under alpha particle and X-ray exposures for dose estimation","volume":"12","author":"Lee","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s13577-021-00650-9","article-title":"USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer","volume":"35","author":"Li","year":"2022","journal-title":"Hum. Cell"},{"issue":"6","key":"10.1016\/j.imbio.2026.153232_bb0105","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00262-009-0813-5","article-title":"Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity","volume":"59","author":"Matsushita","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.imbio.2026.153232_bb0110","first-page":"620","article-title":"Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mdr2.70032","article-title":"Rad51 at the Crossroads: Bridging DNA Repair, Tumorigenesis, and Immune Regulation","volume":"1","author":"Qin","year":"2025","journal-title":"Med Research"},{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283124","article-title":"Moving beyond MARCO","volume":"18","author":"Rosa","year":"2023","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.imbio.2026.153232_bb0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(21)00658-6","article-title":"Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial","volume":"23","author":"Schoenfeld","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.imbio.2026.153232_bb0130","doi-asserted-by":"crossref","unstructured":"Shan L, Xu X, Huang L, Li D, Deng Y, Xue X, Guo S, Huang Y, Zhang X, Yu Y: A novel nor@DHB matrix for direct microbial analysis in lung cancer tissues. Adv. Sci. 2025, 000(000).","DOI":"10.1002\/advs.202504038"},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0135","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0140","first-page":"3949","article-title":"Role of YAP in lung cancer resistance to cisplatin","volume":"16","author":"Song","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12967-023-04260-x","article-title":"Predicting tumor repopulation through the gene panel derived from radiation resistant colorectal cancer cells","volume":"21","author":"Song","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.imbio.2026.153232_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.imbio.2026.153232_bb0155","doi-asserted-by":"crossref","unstructured":"Sun Y, Xiao W, Yu Y, Jiang Y, Xiao Z, Huang D, Zhong T, Li J, Xiang X, He Y et al: Colorectal cancer-derived extracellular vesicles containing HSP70 enhance macrophage phagocytosis by up-regulating MARCO expression. Exp. Cell Res. 2023, 426(2):113565.","DOI":"10.1016\/j.yexcr.2023.113565"},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.18632\/oncotarget.2670","article-title":"CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance","volume":"6","author":"Ventela","year":"2015","journal-title":"Oncotarget"},{"issue":"Suppl. 2","key":"10.1016\/j.imbio.2026.153232_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/resp.13870","article-title":"Radiotherapy treatment for lung cancer: current status and future directions","volume":"25","author":"Vinod","year":"2020","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0170","doi-asserted-by":"crossref","first-page":"20240145","DOI":"10.1002\/VIW.20240145","article-title":"Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non-small-cell lung cancer","volume":"6","author":"Wang","year":"2025","journal-title":"VIEW"},{"issue":"40","key":"10.1016\/j.imbio.2026.153232_bb0175","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg1850","article-title":"YAP drives fate conversion and chemoresistance of small cell lung cancer","volume":"7","author":"Wu","year":"2021","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.imbio.2026.153232_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111542","article-title":"Down-regulation of MARCO associates with tumor progression in hepatocellular carcinoma","volume":"383","author":"Xiao","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12672-022-00515-z","article-title":"CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway","volume":"13","author":"Xin","year":"2022","journal-title":"Discov. Oncol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0190","article-title":"MiR-634 decreases the radioresistance of human breast cancer cells by targeting STAT3","volume":"35","author":"Yang","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.imbio.2026.153232_bb0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/IJN.S287523","article-title":"Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with dual Effects","volume":"16","author":"Yang","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.imbio.2026.153232_bb0200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4103\/jcrt.JCRT_421_18","article-title":"Targeting the canonical Wnt\/beta-catenin pathway in cancer radioresistance: Updates on the molecular mechanisms","volume":"15","author":"Yang","year":"2019","journal-title":"J. Cancer Res. Ther."},{"issue":"46","key":"10.1016\/j.imbio.2026.153232_bb0205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207201119","article-title":"Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imbio.2026.153232_bb0210","doi-asserted-by":"crossref","first-page":"1257173","DOI":"10.3389\/fcell.2023.1257173","article-title":"Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153232_bb0215","doi-asserted-by":"crossref","first-page":"e0475322","DOI":"10.1128\/spectrum.04753-22","article-title":"MARCO inhibits porcine reproductive and respiratory syndrome virus infection through intensifying viral GP5-induced apoptosis","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol. Spectr."},{"issue":"1","key":"10.1016\/j.imbio.2026.153232_bb0220","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11033-023-09201-x","article-title":"The application of MARCO for immune regulation and treatment","volume":"51","author":"Zhou","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.imbio.2026.153232_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110268","article-title":"Numb\/Notch\/PLK1 signaling pathway mediated hyperglycemic memory in pancreatic cancer cell radioresistance and the therapeutic effects of metformin","volume":"93","author":"Zhu","year":"2022","journal-title":"Cell. Signal."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:49:01Z","timestamp":1789634941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0171298526000781"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153232","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MARCO is associated with radiosensitivity in lung cancer through modulation of Hippo signaling","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153232"}}